| Product Code: ETC10223214 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Despite a decline in the CAGR and a significant drop in growth rate from 2023 to 2024, Ireland`s import shipments of prostate-specific antigen blood-based biomarkers continued to be dominated by key exporting countries such as the USA, UK, Germany, Metropolitan France, and Serbia. The high concentration levels measured by the HHI index indicate a strong market presence of these top exporting nations in 2024, highlighting the importance of these trade relationships in meeting Ireland`s demand for such critical healthcare products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2022 & 2032F |
3.8 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2022 & 2032F |
3.9 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2022 & 2032F |
4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about prostate cancer screening and early detection |
4.2.2 Growing prevalence of prostate cancer in Ireland |
4.2.3 Technological advancements in PSA testing leading to more accurate and efficient diagnostics |
4.3 Market Restraints |
4.3.1 Regulatory challenges and evolving reimbursement policies |
4.3.2 Limited access to healthcare services in certain regions of Ireland |
4.3.3 Concerns about overdiagnosis and overtreatment of prostate cancer |
5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2022 - 2032F |
6.1.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2022 - 2032F |
6.1.5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2022 - 2032F |
6.1.6 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2022 - 2032F |
6.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2022 - 2032F |
6.2.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2022 - 2032F |
6.2.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2022 - 2032F |
6.2.5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2022 - 2032F |
6.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2022 - 2032F |
6.3.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2022 - 2032F |
6.3.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2022 - 2032F |
6.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2022 - 2032F |
6.5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2022 - 2032F |
6.5.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.5.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2022 - 2032F |
7 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Adoption rate of PSA testing among men in Ireland |
8.2 Number of healthcare facilities offering PSA testing services |
8.3 Rate of integration of new PSA testing technologies in clinical practice |
9 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2022 & 2032F |
9.4 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2022 & 2032F |
9.5 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2022 & 2032F |
10 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2025 |
10.2 Ireland Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here